Next, we tried to examine whether the enhanced glycolysis process, simulated by supplementing exogenous pyruvate, could rescue the inhibitory effect of melatonin treatment or silencing of ENO1 on BLCA cells. The gene discussed is ENO1; the disease is bladder transitional cell carcinoma.